Suchergebnisse - (Subject:"Drug Combinations")

PubPharm (16)

1

Research progress of drug combination in overcoming drug resistance of CAR-T cell therapy

enthalten in: Zhonghua nei ke za zhi | 2021

von Hu, C. | Xu, K. | Pan, B.

2

Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer

enthalten in: Zhonghua nei ke za zhi | 2020

von Zheng, X. | Tao, G. | Zhang, Y. | +2

3

Treatment of postprandial discomfort syndrome in the elderly : a multi-centered prospective randomized controlled clinical study

enthalten in: Zhonghua nei ke za zhi | 2020

von Wang, G. | Xu, L. | Chen, H. | +16

4

The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation

enthalten in: Zhonghua nei ke za zhi | 2017

von Xiao, Y. | Hu, Y.

5

Prevention of cardiovascular diseases with multiple risk factors based on "Polypill" concepts

enthalten in: Zhonghua nei ke za zhi | 2010

von Guo, X. | Zhao, D.

6

The effects and safety of bortezomib combined with dexamethasone in the treatment of primary systemic amyloidosis

enthalten in: Zhonghua nei ke za zhi | 2009

von Li, J. | Zhao, Y. | Zeng, L. | +2

7

Replacement of third-generation cephalosporins by piperacillin-tazobactam decreases colonization of extended-spectrum beta-lactamases-producing intestinal Escherichia coli

enthalten in: Zhonghua nei ke za zhi | 2007

von Zhao, Z. | Chu, Y. | Wan, J. | +7

8

A clinical analysis of 22 cases of Pneumocystis pneumonia in acquired immunodeficiency syndrome

enthalten in: Zhonghua nei ke za zhi | 2005

von Wang, H. | Li, T. | Wang, A. | +6

9

Antibacterial activity in vitro and clinical use of sulperazon

enthalten in: Zhonghua nei ke za zhi | 1997

von Wang, X. | Shi, Y. | Qin, W.

10

A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS

enthalten in: Zhonghua nei ke za zhi | 1996

von Li, J. | Zhu, Y. | Hu, W.